Stem Cell Summit Can't Excite Investors

• By the tickerspy.com Staff
• On 12:27 pm EDT, Wednesday September 30, 2009

The 2009 World Stem Cell Summit concluded a week ago, and since then the sector's stocks have slipped into the red.

Early last week some of the world's brightest minds in stem cell research met in Baltimore, Maryland for the 2009 World Stem Cell Summit. According to the event's website, topics of discussion ranged from science and medicine to ethics and advocacy. However, despite three days of presentations and panel discussions, apparently nobody said anything that got investors excited about stem cell stocks.

Over the week since the annual conference ajuorned, Stem Cell Stocks Index has slipped by -5.5%, making it one of the ten worst-performing tickerspy Indexes for the period.

Osiris Therapeutics (NASDAQ: OSIR - News) and Opexa Therapeutics (NASDAQ: OPXA - News) are the sector's worst performers over the last week, both falling by double-digit percentages. The latter has rallied from less than $2 to highs over $5.50 in Sepetmber on developments relating to its deal with Novartis (NYSE: NVS - News).

Aastrom Biosciences (NASDAQ: ASTM - News), Neuralstem (AMEX: CUR - News), and Cytori Therapeutics (NASDAQ: CYTX - News) are all giving up more than -3.5% today. Geron (NASDAQ: GERN - News) is up fractionally for the session, though it would need a 6% run to pull it out of negative territory for the last five.

Thermogenesis (NASDAQ: KOOL - News) is bucking the trend over the last week with a 13% gain. The stock picked up speed on Monday after investors learned that the company's CEO Melville Engle bought another 100,000 shares. Pluristem Therapeutics (NASDAQ: PSTI - News) is the stem cell sector's only other stock in positive territory after the last five sessions.

Investors interested in capitalizing on future developments in the stem cell research sector can track the Stem Cell Stocks Index for industry trends and a suite of other performance metrics.

Fun and informative, tickerspy.com is a free investing website where you can track multiple stock portfolios and compare against 250 proprietary Indexes tracking themes from nanotech to agriculture to precious metals. Best of all, tickerspy.com lets you spy on the portfolios of nearly 3,000 Wall Street institutions and hedge funds and see graphs of their performance. Try tickerspy.com today and find out how you stack up against investing legends like Warren Buffett!

Buzz up!